Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Cancer Treatment Reports|March 1, 1987
Phase I study of epirubicin given on a weekly scheduleR Snyder, J Bishop, G Brodie, et al.
The Journal of Urology|February 24, 2009
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomyD R Shepard, R Dreicer, J Garcia, et al.
Australian and New Zealand Journal of Medicine|February 1, 1983
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapyM L Friedlander, J H Kearsley, K Sims, et al.
Cancer Treatment Reports|February 1, 1987
Mitomycin and mitoxantrone in previously treated patients with advanced breast cancerJ F Bishop, D Raghavan, R Woods, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1987
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimensS T Milliken, M H Tattersall, R L Woods, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, V Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyS B Saxman, K J Propert, L H Einhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-upJ A Levi, D Thomson, T Sandeman, et al.
Pageof 17